Chips · Stock report · Qualcomm (NASDAQ: QCOM)
Qualcomm — 19th of 86 chip stocks over a month, then an 11% drop through its 200-day line
The Closelooknet read
Qualcomm (NASDAQ: QCOM) still sits 19th of the 86 stocks in our chip section over one month, with a fall of 9.5%, even after Friday's 11.1% fall. Our money-flow reading (our proprietary flow gauge) is 21.9 and labelled flat, with little change over five days (0.1) or 21 days (-0.8). The stock closed at $164.79, under the average close of the last 200 sessions ($169.52). What we watch: whether it can close back above $169.52 in the coming sessions, or stays under it while the flow reading stays flat.
Where Qualcomm stands among our chip stocks
Qualcomm's one-month move of -9.5% puts it 19th of 86 in our chip section. Its peers fell too. Over the month NVIDIA (NVDA) moved -11.36%, AMD (AMD) -18.02%, Broadcom (AVGO) -5.11% and Global Unichip (GUC) -3.66%.
Qualcomm is 34.4% below its 52-week closing high of $251.02 from 29 May. Broadcom is 32.29% below its high of 2 June. NVIDIA is 14.46% below its 6 October high and AMD 22.27% below its high of the same day. Global Unichip is 11.22% below its 5 October high.
Our money-flow and quality readings
Our money-flow reading for Qualcomm is 21.9, labelled flat, with little change over five or 21 days.
On our scores the stock rates 60 of 100 overall. Quality is 77, balance sheet 74, capital allocation 69, cash quality 65 and momentum 63. Valuation is 51 and growth is 25, the weakest of the scores. The Piotroski score is a check of financial health, scored 6 of 9.
Price trend and the Street
Qualcomm closed at $164.79, 2.8% below its 200-day average of $169.52 and 7.3% below its 50-day average of $177.84. The stock opened 5.7% lower than the prior close.
It is down 3.7% this year and 7.8% over twelve months, though up 8.7% over three months. Its typical daily swing is about 2.6%. Analysts' average target is $211, 13.8% above the last close, with 30 buy, 34 hold and 5 sell ratings and a consensus rating of Hold.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.